Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01939964
Other study ID # 0012
Secondary ID
Status Not yet recruiting
Phase N/A
First received September 7, 2013
Last updated September 7, 2013
Start date November 2013
Est. completion date August 2014

Study information

Verified date September 2013
Source California Allergy and Asthma Medical Group, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

To determine the effect of Activation Mist (AM) on skin wrinkles and appearance.


Description:

This study aims to study the effects of Activation Mist ( AM) on skin wrinkles. It contains a proprietary blend of minerals and nutritional supplements which is patented as "Liquidized Infrared Negative Ion Activation Energy". Active ingredients include sodium bicarbonate, potassium bicarbonate, sodium carbonate, strontium carbonate, gold nanoparticles, calcium, germanium, selenium , zinc, sugar and water. When applied to the skin , it has been shown to reduce the appearance of wrinkles by stimulation of skin fibroblasts to produce new collagen while removing aging dermis cells, facilitate the production of fibrillin proteins and protect the skin from ultraviolet rays.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 2014
Est. primary completion date June 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 30 Years to 80 Years
Eligibility Inclusion Criteria:

1.Male and female subjects aged 30 to 80 years of age with significant facial wrinkles as assessed by the study physician.

Exclusion Criteria:

1. Women who are pregnant or lactating.

2. Subjects with skin conditions that are deemed by the investigator to interfere with the results of this study , including but not limited to: uncontrolled acne, rosacea, atopic dermatitis.

3. Subjects with clinically significant cardiovascular, neurological, renal, endocrine or hematological abnormalities uncontrolled on current therapy.

4. Subjects with history of skin malignancy

5. Subjects with signs of recent sunburn

6. Use of any of the following medications, within 1 week specified of visit 1

1. Systemic steroids

2. Topical steroids used on the face

3. Topical facial preparations including but not limited to: salicylic acid and other acne products, tacrolimus, pimecrolimus.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Skin Wrinkles on Face and Neck Areas

Intervention

Other:
Activation Mist
Activation Mist topical spray

Locations

Country Name City State
United States California Allergy and Asthma Medical Group Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
California Allergy and Asthma Medical Group, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Silicone skin replica analysis Silflo ™ vinyl silicone ( Cuderm Corp.) is applied to the skin areas to be studied and replicas obtained after letting it stand for 3- 5 minutes. The replica technique takes a negative copy of the skin surface which is analyzed by optical profilometry. Optical profilometry ( BioNet Inc.) uses light intensity to assess skin wrinkle texture by objective parameters ( e.g. spacing, breadth, shadows, num wrinkles) This will be performed before and after 8 weeks of treatment. before and after 8 weeks of treatment No
Secondary Wrinkle Score A blinded evaluation will assess wrinkle appearance and grade on a scale of 0 to 5 every week for 8 weeks No
Secondary Photographic evaluation A blinded evaluator will assess photographs of wrinkles and evaluate presence or absence of improvement weekly for 8 weeks No

External Links